Skip to content
logo Impeto Medical
  • Contact Us
  • Distributor Resources
  • Newsletter
      
  • About Us
  • COVID-19
    • Serological tests
    • Protective masks
  • Our Technology
    • TECHNOLOGY
      • Technology principle
      • Sweat function evaluation
      • Peripheral neuropathies detection
      • FAQ
      • Approved cleaning products
    • SUDOSCAN
      • About SUDOSCAN
      • SUDOSCAN principle
      • SUDOSCAN and diabetes
      • A clinically proven test
      • SUDOSCAN applications
    • EZSCAN
      • About EZSCAN
      • EZSCAN principle
      • EZSCAN in practice
  • Clinical research
    • SUDOSCAN
    • EZSCAN
    • Technology studies
    • Join clinical research
  • Worldwide
  • Videos
  • Scientific partners
Menu
2018 Events Calendar

2018 Events Calendar

  • Post author:Impeto Medical
  • Post category:Congress Calendar

Impeto Medical 2018 Events Calendar all around the World.

Continue Reading 2018 Events Calendar

NEWSCAST: IMPETO MEDICAL NEWS

CALENDAR

Congress Calendar

2020 CONGRESS CALENDAR

Meet us on the next 2020 medical congress.

Read more
EVENTS

New findings in diabetology
and diabetic foot

EASD poster

Read more
NEWS

Diabetic complications diagnosis with SUDOSCAN

Combined to COMPASS 31

Read more
  • Contact us
  • Newsletter subscription
  • Privacy Policy
  • Cookies Policy
  • Disclaimer
  • Sitemap

IMPETO MEDICAL IN THE WORLD

  • U.S.A.
  • China
 

N° TVA / VAT FR-52482837366

    • IMPETO MEDICAL SAS
    • OFFICES 9 rue Georges Pitard, Pitard Building, France 75015 Paris, France
    • HEADQUATERS 17, rue campagne Première 75014 Paris, France
  • Telephone+33 (0) 1 4320 1640
Copyright 2005-2020 - Impeto Medical 
Promotional Communication. The medical devices SUDOSCAN & EZSCAN are regulated health products under the CE certification, Class IIa, according to the European Medical Device directive - SGS Belgium, notified body 1639. The test allows screening and monitoring of peripheral autonomic neuropathies. It can be performed in diabetic patients or in patients suffering from neurological diseases involving small fibers damage. As with any diagnostic test, its results must be interpreted in a global context including the clinic and other examinations performed. Please read the user manual instructions carefully. Contact our office for more information. Last update: 2020/06/25
Close Menu
This website uses cookies to ensure you get the best experience on our website.OkLearn more